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Abstract: 
Objectives: the economic impact of smoking on developing countries such as Iran has not been well documented 
still. This study aimed to develop the estimates of the direct costs of medicine for smoking in Iran during 2014. 
Methods: A prevalence-based approach was used to estimate the annual costs of smoking. Then, an econometric 
model was applied to estimate the Smoking-Attributable Fraction (SAF) for direct costs (prescription medicine) of 
smoking-attributable diseases. A variety of sociodemographic, economic, and behavioral factors were controlled by 
the model. Results: In 2014, the estimated proportions of medicine expenditures attributable to smoking in Tehran 
(capital of Iran) were totally 8% for chemotherapy and 1% for other medical treatments. Conclusion: Cigarette 
smoking was found to account for a significant portion of national medical expenditure. The varied range across the 
individuals was due to the difference in smoking prevalence, health status, and other socioeconomic variables used 
in the model. The cost methodology presented here can be useful for policy-making. The levels of cigarette taxes and 
other policies relevant to smoking can be assessed through cost estimates. 
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INTRODUCTION: 
Nowdays, the issue of cancer has received a critical 
attention. The burden that cancer inflicts on health 
and public sectors is a continuing concern within the 
field of economics. Cancer is the leading and the 
second leading causes of deaths in the developed and 
developing countries, respectively [1]. Drugs 
comprise a significant portion of the costs of cancer 
care and hence assessing the Smoking-Attributable 
Fraction (SAF) of medical care costs was aimed in 
this article. It is predicted that by 2020, the number of 
new cases of cancer in the world will enhance to 
more than 15 million people with an increase of 12 
million deaths. Much of the burden of cancer 
incidence, morbidity, and mortality will occur in the 
developing world [2]. 
The high financial burden of cancer can lead to high 
levels of financial distress forcing patients and their 
families to adopt cost-coping strategies, which can be 
detrimental to their physical and emotional well-
being. Financial distress changes the content of 
patient-physician consultations and affects clinical 
decision-making [3]. The changes experienced 
through smoking as a risk factor among cancer 
patients over the past decade have remained 
unprecedented. A risk factor of cancers can be 
cigarette smoking whose relationship with financial 
stress would occur on a common ground. Both would 
probably affect each other, while the severe financial 
stress for smoking households can be twice as large 
as for non-smoking families [4]. 
Literacy and low education levels, traditional beliefs, 
Socio-Economic Status (SES), and employment 
status all influence on cigarette smoking in adult 
males. Although poor people smoke more frequently 
and further spend their incomes on cigarettes, other 
factors like educational level and traditional beliefs 
have been found to influence on cigarette-smoking 
practices in men [5]. Some cancers like lung, 
pharynx, esophagus, bladder, stomach, and kidney 
cancers are caused by smoking as a well-known risk 
factor. Compared to cancer-free adults (44%), 57% 
have been observed to have a smoking history among 
those representing an active cancer or a past history 
of cancer. All age groups of any gender with a history 
of cancer would represent a higher prevalence of 
smoking history. 
Nevertheless, current smoking avoidance is not 
necessarily resulted from a past history of cancer. 
19% of adults with a cancer history and 22% of those 
without cancer show a similar prevalence of current 
smoking. Most strikingly, 46% of young adults with 
a history of cancer appear to be currently smoking 
compared to 25% of cancer-free adults of the same 
ages. Based on gender, it can be said that cancer-free 
women are less likely current smokers than those 
with a history of cancer. However, this pattern is 
reverse among men since those with a cancer history 
display a current smoking rate of 15% as compared to 
25% of those without any cancer histories [6]. 
Findings suggest that the relationships between 
smoking among adolescents and its social and 
personal influences as a part of the developmental 
process of adolescence are similar across all 
countries. These findings point out the importance of 
both personal and social impacts of adolescent 
smoking, which interact in a complex model, 
regardless of culture and smoking rate. 
Smoking is influenced by a host of individual, social, 
and environmental factors that come together in 
complex ways [7]. Many behavioral risk factors, 
chief among them smoking, heavy drinking, and 
obesity, are the known causes of chronic health 
conditions. Chronic health conditions like cancer, 
diabetes, or heart diseases are the primary drivers of 
healthcare spending, disability, and death in turn [8]. 
As it has been concluded through a comprehensive 
systematic review by the World Cancer Research 
Fund (WCRF) and American Institute for Cancer 
Research (AICR), obesity is known as a risk factor 
for several cancers. It can further lead to an increased 
mortality due to poorer treatment and worse 
prognosis of cancer. In the medical literature, the 
correlation between obesity and cancer has been 
found for several decades [9,10]. 
Therefore, much attention has been recently paid to 
obesity and cancer link. Through epidemiological 
studies, obesity has been shown to be associated with 
an enhanced risk of several cancers like leukemia, 
liver, gall bladder, esophagus, breast, gastric, 
pancreatic, kidney, endometrium, and colon cancers. 
The biological mechanisms, including energy balance 
modulation and calorie restriction, varied signaling 
pathways, growth factors, and inflammatory 
processes, which are involved in the relationship 
between cancer and obesity are not well understood 
[9]. A primary prevention through lifestyle and 
environmental interventions remains as the main way 
to reduce the burden of cancers [10]. Other factors, 
such as risk perception and personality (specifically 
sensation seeking) provide a robust history in the 
research performed on seat belt use. 
Seat belt use has been reported to be related to some 
health and driving-related behaviors. Analyses have 
shown that seat belt use in the back seat together with 
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regular walking and adequate sleep are positively 
related to seat belt use in the front seat, whereas 
being a male and having driving errors and smoking 
frequency are negatively related to seat belt use in the 
front seat. The present findings suggest that seat belt 
use can be considered in the context of driver 
behaviors, such as driving errors and violations [11]. 
One framework for understanding belt use could 
involve demarcating the research on psychology 
(internal) or social (external) causes of its use as 
discussed above. Most social scientists would 
probably argue that belt use, as well as other health 
behaviors are a combination of psychological and 
social influences. However, this basic distinction can 
still help develop a framework, through which the 
relative strength of each set of forces can be 
evaluated. Evidence strongly suggests that seat belt 
use is influenced by a person’s perception of risk 
[12]. 
Review articles 
In the USA, it was estimated that US$2·5 trillion 
(18%) of the Gross Domestic Product (GDP) had 
been totally spent on health care in 2009. Compared 
to the USA $11000 per capita, almost $5000 per 
capita ($112·8 billion) had been totally spent on 
healthcare in Australia. Healthcare expenditure of 
GDP percentage in the USA had highly exceeded 
those of other countries, while that of France had 
reached 11%, which was closest to that of the USA 
among other developed countries. In 2010, nearly 5% 
(more than $124 billion) of the total health care costs 
was estimated to have been spent on cancer care in 
the USA. 
Furthermore, 5·6% (£5·86 billion) of the total health 
expenditure spent during 2009-10 in the UK was 
reported by the National Health System (NHS) to be 
related to cancer costs. 
Cancer costs of the total health care expenditure have 
been reported by the diverse healthcare systems to 
range between 4·1% in the Netherlands to 7% in 
Sweden, while the US figure has considerably agreed 
with the data obtained from Europe, Canada, 
Australia, and New Zealand in 2004. Even a rather 
higher percentage (9·3%) of the total health care 
expenditure was allocated to cancer in Japan in 2004 
[13]. 
Hideyuki Akaza (RCAST) noted that in 2011, the 
United Nations (UN) had identified the top killer 
diseases around the world, the majority of which 
were Non Communicable Diseases (NCDs). It is 
estimated that by 2030, the greatest cause of deaths in 
all countries, including developing countries, will be 
cancer [14]. 
The total economic cost of smoking in 2011 was 
estimated to be 24679.9 billion Vietnam Dong 
(VND), which was equivalent to US$1173.2 million 
(nearly 0.97%) of GDP in the same year. The direct 
costs of healthcare reached 9896.2 billion VND 
(US$470.4 million) for inpatients and 2567.2 billion 
VND (US$122.0 million) for outpatients. 
Governmental contribution to these expeditures was 
4534.3 billion VND (US $215.5 million), i.e., 5.76% 
of the health care budget spent in 2011. The indirect 
costs of productivity losses were 2652.9 billion VND 
(US$126.1 million) for morbidities and 9563.5 
billion VND (US $454.6 million) for mortalities, 
which represented approximately 49.5% of the total 
costs of smoking [15]. 
The total therapeutic expenditures attributable to 
smoking in 1993 were assessed to range from 6.6% 
to 14.1% and the SAFs related to home care were 8% 
and 15.9% for nursing at home and in the country as 
a whole, respectively. 
The total Smoking-Attributable Expenditures (SAEs) 
used for medical care have been estimated to range 
from $79.6 million to $8.72 billion. The total SAE 
for the U.S adult residents in 1993 was estimated to 
be $72.7 billion, which accounted for 11.8% of the 
total medical expenditures. Of this total cost, $185 
billion, $7.7 billion, and $35.9 billion were in 
ambulatory care, prescription of total medical 
expenditures, and hospital care, respectively. 
On the other hand, the expenditures of prescription 
medicine use, hospital care SAF, home health 
services, and nursing home care were 9.6%, 25.7%, 
25.4%, and 22.3%, respectively. The health care cost 
of smoking in African-American cities in 2002  was 
$626 million. In 1999, $15.9 billion was the total cost 
of smoking in California, while the costs per resident 
and smoker were estimated to be $475 and $3331, 
respectively. 
The direct cost was 54% of the total (nearly $8.6 
billion), while the indirect costs due to lost 
productivity from illnesses and premature deaths 
were $1.5 billion (10%) and $5.7 billion (36%), 
respectively. The costs of smoking for men and 
women were $9.4 billion and $6.3 billion, 
respectively. 43137 deaths were attributed to 
smoking, which exhibited an average value of 12.4 
years of life lost per death ($132000) from a total of 
535000 years [18]. Significantly smaller SAFs were 
found for women as 8% and  11.4% of the direct 
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costs of smoking were represented for women and 
men, respectively [16]. 
In 1987, the total medical care expenditure was 
estimated to be $308.7 billion and the share of 
smoking was $21.9 billion  (7.1%). Hospital, 
ambulatory physician care, and nursing home care 
costs attributable to smoking accounted for $11.4 
billion, $6.6 billion, and $2.2 billion, respectively [5] 
. 
The direct costs related to 5 smoking-related 
diseases, including lung cancer, cancers of the upper  
aero-digestive tract, chronic obstructive pulmonary 
disease, ischemic heart disease, and stroke were 
estimated to be $470.4 million [17]. 
METHOD: 
A great economic burden is imposed on the society 
by smoking. Both the smokers and nonsmokers, who 
may be exposed to second-hand smoke can be 
involved in the illness. As a result, healthcare 
services and subsequent costs are required. Premature 
deaths are resulted from smoking due to losing time 
for regular activities. Hence, to reduce smoking 
impact on the society, understanding its economic 
burden in terms of both monetary costs and lost time 
and lives can be helpful. 
 
Data 
To estimate SAF in an econometric study, extensive 
and detailed national data on the sociodemographic 
characteristics, health and employment statuses, 
medical conditions, smoking history, and other health 
risk behaviors of each respondent, as well as 
determination of annual healthcare costs by type of 
health care services like inpatient hospitalizations and 
outpatient visits are required. 
This study was conducted in the form of a survey and 
the data were collected via telephone interviews. The 
data were recorded on a digital audio recorder. The 
research was approved by the ethical committee of 
the university and then an informed consent was 
obtained from all the patients. The research data were 
drawn from 3 main sources: Shahid Beheshti Health 
Center, Tehran, and Iran comprising 35500 cancer 
patients altogether. The research focus was on the 
cancer patients residing in Tehran. 
In 2014, about 12000 participants were divided into 2 
groups: the first group had cancers as a result of 
smoking according to ICD10 and the second group 
suffered from cancer not due to smoking. 
The first group included ICD (00-C14 (lip, oral 
cavity, pharynx), C15 (esophagus), C16 (gastric 
cancer), C25 (pancreas), C32 (larynx), C33-C34 
(trachea, lung, bronchus), C53 (cervix, uteri), C64-
C65 (kidney and renal pelvis), and C67 (urinary 
bladder), but not code C92 (acute myeloid leukemia). 
The second group suffered from other cancers. 
The survey design was based on the use of a 
questionnaire, including light, moderate, and heavy 
smoking histories, public and private insurance 
coverages, a range of excellent-to-bad health statuses 
using Likert index, and social and demographic 
characteristics, such as age, marital status, education, 
and family expenditure on a monthly basis. The risk 
behaviors like obesity and seat belt, as well as annual 
expenditures for health care services, such as 
inpatient hospitalization, outpatient visits, ambulatory 
medical care, medicine, etc. were also addressed. 
The successful call rate was about 18% in both 
groups since some patients did not complete the 
survey due to deaths and other reasons. This research 
assessed SAF of medical care costs. Pharmaceutical 
expenditures comprised a significant portion of 
cancer care costs including chemotherapy, hormonal 
therapy, and prescription medication, such as 
antiemtics, anti-depressants, and stimulants of desire 
for supportive care. Also, a prevalence-based annual 
cost approach was applied. 
In the mentioned year, the economic burden of 
smoking was estimated for all the relevant illnesses. 
In this research, a questionnaire including such items 
as a smoking history was utilized. Current smokers 
were defined as those who currently smoked every 
day and who had smoked at least 100 cigarettes in 
their life spans. 
Former smokers were defined as those who did not 
currently smoke, but had smoked 100 cigarettes in 
their life spans. Finally, never-smokers were defined 
as those who had not smoked 100 cigarettes during 
their lifespans. Then, the items were arranged for 
never-smokers, quit>15 years, quit<15 years, light 
smokers, moderate smokers, and heavy smokers. For 
defining current smokers, Hamilton questionnaire 
was employed with 2 questions and 4 answers for 
each question,  while each answer was scored from 0 
to 3.  
The first question was as this: "How many cigarettes 
do you smoke each day?" 0, 1, 2, and 3 were given to 
10 or less, 11-20, 1-30, and 31 or more cigarettes 
each day, respectively. The second question was as 
follows: "How soon  do you smoke your first 
cigarette after you wake up?" The given scores were 
3, 2, 1, and 0 for smoking within 5, 5-30, 31-60, and 
after 60 minutes after waking up, respectively. To 
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determine Heaviness of Smoking Index (HIS), 2 
questions were included, to which the scores of 0-2, 
3-4, and 5-6 were given to light, moderate, and heavy 
addictions, respectively.  
Financial stress was defined for one who had had to 
borrow money or get social assistance to afford food 
or housing within the last year. The demographic 
variables included age, for which the 3 dummies of 
18 (18≤age<35), 35 (35≤age<65), and 65 (65 
>age≥65) years were created, gender (male and 
female), educational level (illiterate, less than high 
school, high school graduate, undergraduate, and 
postgraduate), and marital status (single, married, 
widowed, and divorced). The socioeconomic 
variables consisted of monthly expenditure and 
health insurance coverage (public and private 
insurance). 
Other risk behaviors were Body Weight (BW) status 
(Body Mass Index (BMI), which was defined as 
weight in kilogram divided by height in square 
meters (obesity ≠ 30 kg/m2), smoking-attributable 
health care expenditure used for prescription 
medicines, and health status definition (excellent or 
very good, good, fair, and bad) used to assess 
smoking-attributable cost for  a medical cure. A 
reduced form of the model was employed as a 
simplified system, in which each effect was 
represented as a dependent variable in an equation, 
while the causal explanatory variables did not include 
any other effects in the system. 
We followed an approach to modeling annual 
medical expenditures pioneered by Duan et al. 
(1983). The model was made up of 2 central 
equations for each type of medical services as a 
medicine, while the dependent variable in the first 
equation was as a dummy variable indicating whether 
an individual had had any positive medical expenses 
in the category during the year. This equation was 
estimated as a logistic regression for the independent 
variable. The dependent variable in the second 
equation was the natural logarithm of the annual total 
expense of the medicine, which was positive. The 
equation was fitted only through the observations, for 
which the related cost was strongly positive. Some 
independent variables together with an intercept were 
incorporated into both equations. For each attribute, 2 
fitted values were calculated for medical care 
expenses. The first and second fitted expenditures set 
the given values of the independent variables and the 
value of smoking variable to zero, respectively. 
Therefore, the second fitted expenditure depended on 
the individual's expected expense as if he/she was a 
non-smoker, while all the other factors were held 
constant.  
Then, the 2 estimated expenditures were summed 
over all the individuals in the sample to produce 2 
aggregates of fitted expenditure and fitted 
expenditure as if anyone was a non-smoker. The 
difference between them was related to the smoking-
attributable cost.  
Upon calculating the attributable risk figures, they 
were multiplied by the estimates of total expenditures 
for the relevant subset of the cancer population to 
produce smoking-attributable expenditures for 
medical care. 
Calculation formula based on WHO Toolkit: 
The reduced form of the SAF econometric model 
only consisted of 2 basic equations: 
Prob (Xjk>0) = f1 (Sj, Xj, Yj, Zj) …… (Eq IV.10) 
Log (Xjk|Xjk>0) = f2 (Sj, Xj, Yj, Zj) …… (Eq 
IV.11) 
Where 
Xjk = person j’s annual expenditures for healthcare 
service type k (e.g., inpatient hospitalizations, 
outpatient visits, and medications) in a given year for 
all kinds of diseases including smoking-related 
diseases and other diseases 
Log = logarithmic transformation 
Sj = person j’s smoking status 
Xj = person j’s sociodemographic characteristics 
(such as age, race, ethnicity, geographic region, 
marital status, education, and family income) 
Yj = person j’s other risk behaviors (such as alcohol 
drinking and obesity) 
Zj = person j’s health insurance coverage 
Equations (IV.10)-(IV.11) formed the 2-part model 
for health care expenditures. In Equation (IV.10), the 
dependent variable was the probability of having 
positive annual expenditures in a given year. In 
Equation (IV.11), the dependent variable was the 
logarithm of annual costs for those persons with 
positive expenditures. Both equations of the 2-part 
model contained the same independent variables: 
smoking history, sociodemographic factors, other risk  
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behaviors, and health insurance coverage. The first 
equation was estimated by a probit or logit model. 
The second equation was estimated by the ordinary 
least squares method [WHO]. 
 
Where 
EXPn = predicted expenditures for a never-smoker n 
EXPc = predicted expenditures for a current smoker c 
EXPf = predicted expenditures for a former smoker f 
EXPc n = predicted expenditures for a hypothetical 
“nonsmoking current smoker” c, who has the 
identical characteristics of a current smoker except 
that he/she is assumed to be a never-smoker 
EXPf n = predicted expenditures for a hypothetical 
“nonsmoking former smoker” f, who has the identical 
characteristics of a former smoker except that he/she 
is assumed to be a never-smoker 
Nn = total number of never-smokers 
Nc = total number of current smokers 
Nf = total number of former smokers 
RESULTS: 
A hallmark of cancer, cost, and pain were the major 
problems in the public and health sectors. There was 
a common sense for the fact that one of the most 
important risk factors could cause a cancer. It is 
worthwhile to note that Social Impact Assessment 
(SIA) has become a part of project planning, policy 
evaluation, and environmental impact assessment. 
Moreover, gender, age, monthly expenditure, marital 
status, education level, medical insurance status, 
safety-belt fastening, obesity, and financial stress are 
controlled by all such models. 
 
Table 1: Number of patients in each group completing the questionnaire as participants, as well as the lost 
sample rate due to death 
 
 
 
All participants 11294 patients 12.2% died  
Not Attributed to Smoking 8431 patients 8% died 1565 participants 
Attributed to Smoking 2863 patients 24.3% died 521 participants 
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Table 2: the descriptive statistics of demographic and SES variables 
Variables  Attributed to smoking Not Attributed to smoking 
Sex  66% 39.2% 
Male 34% 60.8% 
Age Female 4.4 % 8.6% 
<35 years 56.3% 56.9% 
35-<65 years 39.1% 34.4% 
Educational  
Status 
>65 years 15.3 10.6 
Illiterate 26.6 21 
Elementary 13 12.9 
School 24.3 30.8 
High school 4.6 4.3 
Bachelor  9.2 14.7 
Undergraduate 4.4 4.2 
Master's degree 1.5 1.3 
Job status P.H.D.  25.1% 
9.8% 
25.7% 
37.9% 
1.5% 
15.5% 
10% 
42.3% 
28% 
0.2% 
Material status Employee 
Jobless 
Housewife 
Retired 
Others 
86.3% 
3.5% 
1.9% 
8.1% 
79.6% 
8.6% 
1.3% 
10.5% 
Obesity  Marie d 
Single 
Divorced 
Widow 
86.2% 
13.8% 
80.1% 
19.9% 
Financial stress Under obesity status 
Obese 
54.7% 
45.3% 
48% 
52% 
Seat belt 
fastening  
Having a financial stress 
Lacking a financial stress 
84.8% 
15.2% 
93.1% 
6.9% 
Health status Fastening a seat belt 
Failing to wear a seat belt 
3.4% 
29.9% 
36.6% 
29.9% 
13.5% 
45.6% 
29.9% 
11% 
Public insurance Excellent, very good  
Good  
Fair 
Bad 
96.5% 
3.5% 
98.4% 
1.6 
Private 
insurance 
Having public insurance  
Lacking public insurance 
60.5% 
395% 
63.9% 
36.9% 
Smoking 
history 
Having a Private insurance  
Lacking a private insurance 
53.2% 
18.4% 
11.5% 
6.1% 
10.7% 
99% 
 Never smoking 
Quit<15 years 
Quit>15 years 
Moderate smoking  
Heavy smoking 
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Table 3: Estimates and test statistics for each parameter in SAF of medical care expenditure 
Variables Probability of 
positive medical 
expense   
 Log of medical 
expense 
 
 Estimate χ2  T statistics 
Intercept -0.229457 -0.355411 6.627987 4.035563 
Male 0.206869 1.309926 0.177017 0.426195 
Married state -0.325808 -1.137431 -1.186091 -1.449587 
Singleness 0.212133 0.352054 0.450947 0.302345 
Divorced state *-0.463511 -2.043104 -1.205405 -1.901703 
Income *0.408195 7.749703 1.182153 *9.141487 
35-<65 years old 0.133525 0.502731 0.258715 0.347261 
>65 years old 0.462946 1.587459 1.126568 1.403840 
BMI -0.321910 -1.882880 -1.020495 *-2.164410 
Good health 
status 
0.257674 1.079427 0.880450 1.304660 
Fair health status 0.073936 0.302838 0.336260 0.487387 
Bad health status *0.709118 2.342617 2.155437 *2.737285 
Public insurance -0.312570 -0.563919 -0.757572 *-0.565845 
Private insurance -0.145656 -0.956848 -0.446154 -1.121335 
Passivity 0.164774 0.986886 0.227930 0.531021 
Seatbelt use *0.646231 2.534041 1.538990 *2.527949 
Under high school 
education 
-0.119806 -0.528556 -0.392641 -0.676130 
Undergraduate -0.311561 -1.398974 -0.941930 -1.635738 
Postgraduate -0.438351 -1.240949 -0.975504 -1.059665 
Quit smoking<15 
years 
0.012197 0.040974 0.403881 0.552607 
Quit smoking<15 
years 
0.195909 0.498265 0.429456 0.482336 
Heavy smoking 0.083132 0.156511 0.690896 0.561275 
     
*significant at the confidence level of 90% 
The reduced form of the parameter estimating the 
SAF of medical care costs in cancer patients:  
The SAF percentage of chemotherapy expenditure 
and other medicines were assessed to be 0.0808 (~8% 
of the total cost of cancer treatment) and 0.012 (~1% 
of the total cost of cancer treatment), respectively. 
Smoking-Attributable Fraction (SAF) would be the 
fraction of a disease not occurred in a population if 
the effects associated with smoking are absent. 
 
DISCUSSION: 
These assessments are conservative for numerous 
reasons. We did not take into account costs 
attributable to passive smoking, fires caused by 
cigarettes, non-health part costs such as a carriage to 
providers, and costs of smoking ending programs and 
other interferences to control smoking.  
 
In which health expenses were modelled with a 
reduced form model. Our study was based on a 
causal relationship structure established by L Miller 
and colleagues,which we believe yields more 
accurate estimates. 
 
The V Miller and L Miller models are compared in 
factor elsewhere.Different from L Miller,the current 
study used more recent data sources. Also, we 
involved only the ‘‘biological effect’’ in the 
calculation of SAFs while Miller involved both the 
‘‘biological t’’ and the ‘‘mixed effect’’. Because 80–
90% of the entire effect came from the biological 
factor and the biological SAFs were more steady, this 
development improves the method. 
 
Without the tobacco controller package, smoking 
associated costs would have been even higher. The 
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question has been raised as to whether smokers are 
compensating for their smoking behaviors. 
 
An associated question is whether cigarette taxes are 
at the suitable level. From an economic perception, 
the tax should be set of protection the external costs 
of smoking, the costs enforced by smokers on others. 
While we did not estimate the percentage of costs 
that are internal versus external.  
 
However, it must also be well-known that from an 
equity perspective, if shares of the tobacco tax rise is 
to be passed on to smokers, the incomes raised up 
should be used to help them abandon smoking and 
get health care for smoking related illnesses they may 
already have. The public health impact of cigarette 
smoking in IRAN is enormous in terms of the large 
amount of avoidable illnesses, premature deaths, and 
high health care costs and productivity losses. 
Politicians must continue to push legislature and 
orders that encourage people to abandon or to never 
take up smoking. 
 
This paper was the first investigation into the SAF of 
medical care costs in cancer patients in Iran. 
However, some limitations were inevitable in the 
study. For example, there were no center-related data 
available for a smoking history that linked a 
household expenditure to cancer and the costs of 
health insurance and private insurance for cancers. 
Another limitation was that the research was 
conducted only on a cancer population in one 
province, regardless of other provinces and other 
diseases caused by smoking like cardiovascular and 
respiratory diseases.  
 
The third limitation was the death rate in the cancer 
patients and time of the survey. The survey was 
conducted during 2014 on the patients who had 
registered during 2012, while some of them were lost 
in the meanwhile. Thus, these limitations might have 
underestimated SAF of medical care costs. The main 
focus of the issue in this article is a worthwhile 
endeavor. The research will pave the way, more 
specifically, for developing policies to quit smoking 
with respect to SES. These findings suggest several 
courses of action for changing policies. 
Although the factors included in the model were 
unable to fully explain the relationship between SES 
and smoking, the types of services face a number of 
challenges in supporting more disadvantaged 
smokers to quit. Most of the identified barriers were 
related to the individual conditions of these smokers. 
Therefore, these factors will need to be identified 
through the services if appropriate tailored behavioral 
supports are to help us to address them (session 
Rosemary). SES can be persistent over time due to 
poor health and affect multiple outcomes of diseases 
through their risk factors and mechanisms. Tobacco 
use alone has been found to be responsible for 50%-
65% of the difference in the mortality rates based on 
SES (Session Rosemary). Concerns have arisen in 
comparing SAF of medical care costs in the health 
sector with its burden on the public sector because of 
lacking formal information and transparent data on 
the incomes and taxes gained from the sale of 
cigarettes.  
 
Nonetheless, this paper took a new look at the 
healthcare system. Primary prevention of cancers 
through lifestyle and environmental interventions 
remains as the main way to reduce the burden of 
cancers. 
Furthermore, reduction of exposure to the key 
behavioral and environmental risk factors can lead to 
the prevention of a substantial proportion of deaths 
from cancer. 
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